Natural History and Prognosis of Chronic Hepatitis B Patients in the Indeterminate Phase
The indeterminate phase patients had a high-risk transition to active phase, and antiviral therapy can reduce the incidence of developing HCC and cirrhosis.
Authors
- Xiaoli Xi (ORCID: https://orcid.org/0000-0003-4349-1308)
- Bin Wu (ORCID: https://orcid.org/0000-0001-9039-9681)
- Yidong Yang (ORCID: https://orcid.org/0000-0002-3892-1687)
- Yinan Huang (ORCID: https://orcid.org/0000-0002-8909-0385)
- Hao Jiang (ORCID: https://orcid.org/0000-0001-7955-1363)
- Yiming Lei (ORCID: https://orcid.org/0000-0003-3618-2347)
- Hongsheng Yu (ORCID: https://orcid.org/0000-0003-2548-7882)
- Mingkai Li
- Bilan Yang
Institutions
- Sun Yat-sen University (CN)
- Key Laboratory of Guangdong Province (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- Eighth Affiliated Hospital of Sun Yat-sen University
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1111/jgh.16849
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- National Natural Science Foundation of China